PL3997063T3 - Zastosowanie metastabilnej odmiany krystalicznej i sposób jej wytwarzania - Google Patents

Zastosowanie metastabilnej odmiany krystalicznej i sposób jej wytwarzania

Info

Publication number
PL3997063T3
PL3997063T3 PL20735518.1T PL20735518T PL3997063T3 PL 3997063 T3 PL3997063 T3 PL 3997063T3 PL 20735518 T PL20735518 T PL 20735518T PL 3997063 T3 PL3997063 T3 PL 3997063T3
Authority
PL
Poland
Prior art keywords
production
application
metastable crystal
crystal variant
variant
Prior art date
Application number
PL20735518.1T
Other languages
English (en)
Inventor
Thomas GÜTHNER
Franz Thalhammer
Jürgen SANS
Original Assignee
Alzchem Trostberg Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102019118894.6A external-priority patent/DE102019118894A1/de
Priority claimed from DE102019118893.8A external-priority patent/DE102019118893A1/de
Application filed by Alzchem Trostberg Gmbh filed Critical Alzchem Trostberg Gmbh
Publication of PL3997063T3 publication Critical patent/PL3997063T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL20735518.1T 2019-07-12 2020-06-25 Zastosowanie metastabilnej odmiany krystalicznej i sposób jej wytwarzania PL3997063T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102019118894.6A DE102019118894A1 (de) 2019-07-12 2019-07-12 Metastabile Kristallmodifikation und Verfahren zu deren Herstellung (II)
DE102019118893.8A DE102019118893A1 (de) 2019-07-12 2019-07-12 Metastabile Kristallmodifikation und Verfahren zu deren Herstellung (I)
PCT/EP2020/067838 WO2021008844A1 (de) 2019-07-12 2020-06-25 Metastabile kristallmodifikation und verfahren zu deren herstellung (ii)

Publications (1)

Publication Number Publication Date
PL3997063T3 true PL3997063T3 (pl) 2023-10-23

Family

ID=71409379

Family Applications (3)

Application Number Title Priority Date Filing Date
PL20735519.9T PL3997064T3 (pl) 2019-07-12 2020-06-25 Sposób wytwarzania metastabilnej odmiany krystalicznej kwasu n-(aminoiminometylo)-2-aminoetanowego (iii)
PL20735517.3T PL3997062T3 (pl) 2019-07-12 2020-06-25 Metastabilna odmiana krystaliczna i sposób jej wytwarzania (i)
PL20735518.1T PL3997063T3 (pl) 2019-07-12 2020-06-25 Zastosowanie metastabilnej odmiany krystalicznej i sposób jej wytwarzania

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PL20735519.9T PL3997064T3 (pl) 2019-07-12 2020-06-25 Sposób wytwarzania metastabilnej odmiany krystalicznej kwasu n-(aminoiminometylo)-2-aminoetanowego (iii)
PL20735517.3T PL3997062T3 (pl) 2019-07-12 2020-06-25 Metastabilna odmiana krystaliczna i sposób jej wytwarzania (i)

Country Status (15)

Country Link
US (4) US12252460B2 (pl)
EP (5) EP3997065B1 (pl)
JP (2) JP7633189B2 (pl)
KR (2) KR102648292B1 (pl)
CN (5) CN113710648B (pl)
BR (1) BR112021022116A2 (pl)
CO (2) CO2021016703A2 (pl)
ES (3) ES3017332T3 (pl)
HU (3) HUE063674T2 (pl)
IL (3) IL287827B2 (pl)
MX (2) MX2022000499A (pl)
PH (2) PH12021552734A1 (pl)
PL (3) PL3997064T3 (pl)
WO (4) WO2021008845A1 (pl)
ZA (4) ZA202108515B (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3997065B1 (de) 2019-07-12 2023-08-02 Alzchem Trostberg GmbH Verfahren zur herstellung einer metastabilen kristallmodifikation von n-(aminoiminomethyl)-2-aminoethansäure (iv)
CN115894392B (zh) * 2022-12-02 2024-11-12 中国科学院福建物质结构研究所 (c3h8n6i6)·3h2o化合物、双折射晶体及其制法和用途
CN120659772A (zh) 2023-02-06 2025-09-16 赢创运营有限公司 制备n-胍基氨基酸的方法
WO2024165344A1 (en) * 2023-02-06 2024-08-15 Evonik Operations Gmbh Process for producing free-flowing particles comprising or consisting of an n-guanylamino acid

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2654779A (en) * 1950-12-23 1953-10-06 Int Minerals & Chem Corp Method of preparation of guanidino fatty acids
DE964590C (de) * 1950-12-23 1957-05-23 Int Minerals & Chem Corp Verfahren zur Herstellung von Glykocyamin
US2620354A (en) 1951-01-12 1952-12-02 Int Minerals & Chem Corp Production of guanidino fatty acids
CH587268A5 (en) 1972-06-29 1977-04-29 Ciba Geigy Ag Substd carboxylic acid derivs - broad spectrum antibiotics and inters
JPS6054320A (ja) 1983-08-31 1985-03-28 Morishita Seiyaku Kk 腎疾患治療剤
SE502756C2 (sv) 1990-02-06 1996-01-08 Rexolin Chem Ab Förfarande för rening av mandelsyra-N,N-dietylamid
US6083549A (en) * 1995-07-19 2000-07-04 Ajinomoto Co., Inc. Taste-improving agent and a food having improved taste
DE19860048A1 (de) 1998-12-23 2000-06-29 Basf Ag Verfahren zur Herstellung von Guanidinderivaten
US6518243B1 (en) 1999-04-02 2003-02-11 Trustees Of Princeton University Desleucyl glycopeptide antibiotics and methods of making same
BRPI0511842B1 (pt) 2004-06-09 2014-08-12 Alzchem Trostberg Gmbh Uso de ácido guanidino acético como aditivo para ração animal
DE102006016227A1 (de) 2006-04-06 2007-10-11 Degussa Gmbh Verfahren zur Herstellung von Kreatin, Kreatin-Monohydrat oder Guanidinoessigsäure
FR2901472B1 (fr) 2006-05-24 2010-08-13 Oreal Procede de defrisage des fibres keratiniques avec un moyen de chauffage et des agents denaturants
DE102007004781A1 (de) 2007-01-31 2008-08-07 Alzchem Trostberg Gmbh Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels
DE102007034102A1 (de) * 2007-07-21 2009-01-22 Alzchem Trostberg Gmbh Abriebfeste und rieselfähige Glycocyamin-haltige Formlinge und Verfahren zu deren Herstellung
DE102007053369A1 (de) 2007-11-09 2009-07-02 Alzchem Trostberg Gmbh Verwendung einer eine Kreatin-Komponente enthaltende Zusammensetzung zur Verbesserung der männlichen Fruchtbarkeit
CN101525305B (zh) 2009-04-17 2012-01-04 北京君德同创农牧科技股份有限公司 胍基乙酸及其盐的合成方法
JP5745507B2 (ja) 2009-05-20 2015-07-08 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ グリシン−ｎ，ｎ−二酢酸の１種以上の誘導体および／またはグルタミン−ｎ，ｎ−二酢酸の１種以上の誘導体を含む粉末ならびにメチルグリシン−ｎ，ｎ−二酢酸三ナトリウム塩粉末の調製方法
US20120225371A1 (en) 2011-03-03 2012-09-06 Los Alamos National Security, Llc Ionomer for alkaline fuel cell
CN102329250A (zh) 2011-07-22 2012-01-25 周彬 胍基乙酸的化学合成方法
CN102702032A (zh) 2012-05-10 2012-10-03 江苏远洋药业股份有限公司 胍基乙酸的合成方法
JP2014094999A (ja) 2012-11-07 2014-05-22 Polyplastics Co ポリアセタール共重合体の製造方法
CN105777594A (zh) 2014-12-26 2016-07-20 王建华 一种硫醇化合物的清洁生产方法
CN106361736B (zh) 2015-07-24 2020-02-07 上海医药工业研究院 一种胍基化合物的应用
CN105503659A (zh) 2016-01-29 2016-04-20 浙江汇能生物股份有限公司 一种高纯度高收率胍基乙酸的合成方法
GB201603571D0 (en) * 2016-03-01 2016-04-13 Univ Warwick Markers for skeletal disorders
JP2018063208A (ja) * 2016-10-14 2018-04-19 Ｂｌｏｏｍ Ｔｅｃｈｎｏｌｏｇｙ 株式会社 終末糖化産物の濃縮方法
EP3997065B1 (de) 2019-07-12 2023-08-02 Alzchem Trostberg GmbH Verfahren zur herstellung einer metastabilen kristallmodifikation von n-(aminoiminomethyl)-2-aminoethansäure (iv)

Also Published As

Publication number Publication date
BR112021024244A2 (pt) 2022-04-12
US20250296911A1 (en) 2025-09-25
KR20220034035A (ko) 2022-03-17
US20220204443A1 (en) 2022-06-30
WO2021008846A1 (de) 2021-01-21
KR102754700B1 (ko) 2025-01-14
PH12021552734A1 (en) 2022-07-11
CN113710648A (zh) 2021-11-26
HUE071413T2 (hu) 2025-08-28
EP3997062C0 (de) 2025-02-26
US12252460B2 (en) 2025-03-18
ZA202109576B (en) 2022-11-30
EP3997063C0 (de) 2023-08-02
EP3997064B1 (de) 2023-08-09
PL3997062T3 (pl) 2025-06-16
ES2954944T3 (es) 2023-11-27
ZA202211321B (en) 2023-11-29
WO2021008843A1 (de) 2021-01-21
ES2955483T3 (es) 2023-12-01
CO2021016703A2 (es) 2022-03-18
PL3997064T3 (pl) 2023-11-20
JP2022540451A (ja) 2022-09-15
CN113710648B (zh) 2023-09-12
CN115594615B (zh) 2023-11-07
MX2022000499A (es) 2022-02-03
JP7633189B2 (ja) 2025-02-19
JP7403624B2 (ja) 2023-12-22
EP3997064A1 (de) 2022-05-18
BR112021026604A2 (pt) 2022-05-10
JP2022540331A (ja) 2022-09-15
IL287827B1 (en) 2024-05-01
HUE063674T2 (hu) 2024-01-28
EP3997062A1 (de) 2022-05-18
IL275659B2 (en) 2023-03-01
EP4296262A1 (de) 2023-12-27
EP3997062B1 (de) 2025-02-26
MX393907B (es) 2025-03-24
IL275660B2 (en) 2023-06-01
WO2021008844A1 (de) 2021-01-21
US20220388948A1 (en) 2022-12-08
ZA202200283B (en) 2023-04-26
CO2022000495A2 (es) 2022-01-28
KR20220032526A (ko) 2022-03-15
IL275659A (en) 2021-01-31
CN114072378B (zh) 2024-02-02
CN114096519B (zh) 2023-09-15
CN115594615A (zh) 2023-01-13
EP3997065B1 (de) 2023-08-02
IL287827A (en) 2022-01-01
WO2021008845A1 (de) 2021-01-21
IL275660B1 (pl) 2023-02-01
US11512047B2 (en) 2022-11-29
IL275660A (en) 2021-01-31
EP3997063A1 (de) 2022-05-18
EP3997065A1 (de) 2022-05-18
ES3017332T3 (en) 2025-05-12
CN113784947A (zh) 2021-12-10
EP3997064C0 (de) 2023-08-09
US12351543B2 (en) 2025-07-08
IL287827B2 (en) 2024-09-01
PH12021552952A1 (en) 2022-07-25
HUE063187T2 (hu) 2024-01-28
EP3997063B1 (de) 2023-08-02
KR102648292B1 (ko) 2024-03-15
EP3997065C0 (de) 2023-08-02
US20220289670A1 (en) 2022-09-15
CN114072378A (zh) 2022-02-18
CN114096519A (zh) 2022-02-25
ZA202108515B (en) 2023-01-25
CN113784947B (zh) 2023-09-29
IL275659B (en) 2022-11-01
MX2022000519A (es) 2022-07-13
BR112021022116A2 (pt) 2022-02-08

Similar Documents

Publication Publication Date Title
IL292754A (en) Method of synthesis
PL3788044T3 (pl) Związki hamujące rip1 oraz sposoby ich wytwarzania i wykorzystania
PL3997063T3 (pl) Zastosowanie metastabilnej odmiany krystalicznej i sposób jej wytwarzania
EP3575285A4 (en) LSD1 INHIBITOR, PROCESS OF PREPARATION AND APPLICATION
EP3816150C0 (en) M-DIAMIDE COMPOUND, ITS PREPARATION METHOD AND ITS USE
IL286492A (en) Sialidase-resistant saccharide and method of making and using the same
PL3781563T3 (pl) Inhibitory HPK1, sposób ich wytwarzania oraz ich zastosowanie
EP3620555A4 (en) COMPOSITE CESIUM FLUOROBORATE, NON LINEAR OPTICAL CESIUM FLUOROBORATE CRYSTAL, RELATED PREPARATION PROCESS AND USE
HRP20260295T1 (hr) Kristalni oblici inhibitora btk
PL3586071T3 (pl) Szyba zespolona, sposób jej wytwarzania i jej zastosowanie
PL3583644T3 (pl) Materiały elektrodowe i sposoby ich wytwarzania
PT3764047T (pt) Método e instalação de produção de hidrogénio líquido
LT3740475T (lt) Somatostatino moduliatorių gamybos procesas
PL4046129T3 (pl) Sposób wytwarzania
IL292377B1 (en) Superfine compounds and production thereof
PL4035219T3 (pl) Materiał i sposób jego wytwarzania
PL3380241T3 (pl) Jednolita serologiczna pipeta i sposoby jej produkcji
PL3877395T3 (pl) Przemysłowy sposób otrzymywania estetrolu o wysokiej czystości
IL285546A (en) Compounds and methods for reducing kcnt1 expression
IL286485A (en) Pi4-kinase inhibitors and methods of using the same
PL3942107T3 (pl) Sposób wytwarzania
IL290185A (en) Solid state forms of risdiplam and process for preparation thereof
PL3652148T3 (pl) Amorficzna postać trifenylooctanu wilanterolu i sposby jej wytwarzania
EP3981768A4 (en) POLYMORPH OF A CDK9 INHIBITOR, METHOD FOR PREPARING THE POLYMORPH AND USE THEREOF
PL3863759T3 (pl) Reaktor kawitacyjny i sposób jego wytwarzania